Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people starting semaglutide for weight management ask whether adding l-carnitine could speed their results. It is a reasonable question. L-carnitine is a naturally occurring compound involved in fatty-acid transport within cells, and it is widely sold as a supplement marketed for fat metabolism and exercise recovery. But the honest answer, based on current UK clinical evidence, is that there is no published clinical trial showing a meaningful benefit from combining l-carnitine and semaglutide specifically, and a prescriber's guidance should always take priority over any supplement decision while you are on a prescription medicine. Semaglutide is a prescription-only medicine, and starting it requires a formal clinical assessment by a qualified prescriber who can consider your full health picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by mimicking the hormone GLP-1, which acts on receptors in the brain and gut to reduce appetite, slow gastric emptying and improve blood-sugar regulation. In the STEP 1 trial, published in the New England Journal of Medicine, adults taking 2.4 mg semaglutide lost an average of around 15% of their body weight over 68 weeks, alongside lifestyle changes. It acts on a specific biological pathway with a well-documented mechanism.
L-carnitine plays a different, more basic role. It shuttles long-chain fatty acids into the mitochondria, where they are burned for energy. Your body synthesises it from lysine and methionine, and most people eating a mixed diet have adequate levels. A misconception worth putting to rest: l-carnitine does not directly "burn" fat in the way supplement marketing often implies. It supports a transport process that only matters when your carnitine status is genuinely low, which is uncommon in healthy adults who eat enough protein. You can read about the pharmacology of semaglutide on our main overview page if you want the full mechanism before deciding anything.
The two compounds operate through unrelated pathways. That is not the same as saying they are incompatible, but it does mean any claimed synergy deserves scrutiny.
There is a small body of research suggesting l-carnitine supplementation may modestly support weight management in people who are deficient, and some limited trials have explored it alongside older diabetes or metabolic medicines. None of those trials involved semaglutide or Wegovy specifically. As of summer 2026, no published randomised controlled trial has tested l-carnitine and semaglutide together in humans with obesity.
Some researchers have pointed to l-carnitine's potential role in supporting mitochondrial function and reducing oxidative stress, and animal-model studies have combined it with GLP-1 receptor agonists with mixed results. These findings are genuinely interesting, but animal models do not translate directly to human outcomes, and the supplement industry tends to promote them as though they do. The NHS patient information on semaglutide makes no mention of l-carnitine in either the interactions section or the lifestyle guidance, which reflects the current evidence base accurately.
People combining l-carnitine and Wegovy in online communities often report that they simply felt more energetic, which may reflect a genuine effect, a placebo response, or the well-established improvement in energy that comes from losing weight itself. Anecdote is not a substitute for trial data. For those who want to understand how semaglutide interacts with other aspects of health, our page on how semaglutide relates to erectile dysfunction is one example of the kinds of nuanced questions our clinical team covers.
Even when a supplement appears safe in isolation, adding it during GLP-1 treatment introduces variables worth thinking through. Semaglutide slows gastric emptying, which can alter how and when other substances are absorbed from your gut. That effect applies to medicines and, to a lesser degree, supplements. If you are taking l-carnitine in liquid or capsule form, absorption timing may shift in ways that are difficult to predict without clinical guidance.
There is also a nutritional consideration specific to semaglutide and Wegovy. Because appetite falls significantly on treatment, some people eat much less protein than usual. L-carnitine is synthesised from amino acids in protein-containing foods, so ensuring adequate protein intake is arguably a better strategy for maintaining healthy carnitine status than reaching for a supplement. If protein intake is genuinely your concern, a registered dietitian is better placed to help than a supplement label. For more on how semaglutide affects your body week to week, our guide to what to expect in the first weeks on semaglutide covers the appetite and dietary changes most people notice early on.
On the question of cost: l-carnitine supplements cost a few pounds a month, so this is not a large financial decision. But it is still worth asking your prescriber before you start, because that conversation costs nothing and gives you a clear, personalised answer. If you want to understand what a full private semaglutide consultation involves and what it costs, you can read our transparent pricing context for Wegovy in the UK.
The clearest practical advice is to tell whoever manages your Wegovy prescription that you are considering l-carnitine supplementation. That applies whether you are already on treatment or enquiring about starting. A GPhC-registered prescriber can factor in your diet, any existing conditions, and what dose you are on before giving you a personalised view, and if you are moving through the programme our page on progressing to the next semaglutide dose covers what that stage of treatment typically looks like. At nume, a real clinician reviews your consultation the same day, not automated software, so these nuanced questions can be addressed properly rather than bounced to a generic FAQ. Our clinical team profiles are on the clinical leadership page if you want to know more about who is reviewing your case.
People sometimes worry that asking about supplements will seem frivolous to a prescriber. It will not. A question our prescribers hear regularly is whether it is safe to continue something bought online once a new prescription medicine starts. That is exactly the right question to ask, and it is exactly what the consultation is for. If you are further along in your treatment journey, our guide to what to expect at the higher semaglutide doses explains how the programme develops over time. If you are ready to begin, check your eligibility for a free consultation and our prescribers will take it from there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.